Home > Insider Trading > Filing (0001062993-20-004556)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
819050	Brickell Biotech Inc.	BBI	Biological Products, (No Disgnostic Substances) (2836)	930948554

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1225341	T Dennison Veru	C/O Brickell Biotech, Inc. 5777 Central Avenue, Suite 102 Boulder CO 80301		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-09-14	19,642	$0.00	7,230	No	5	G	Direct
Common Stock	Acquisiton	2020-09-15	13,580	$0.81	20,810	No	4	A	Direct
Common Stock	Acquisiton	2020-09-15	15,355	$0.81	36,165	No	4	P	Direct
Common Stock	Acquisiton	2020-09-16	14,645	$0.80	50,810	No	4	P	Direct
Common Stock	Acquisiton	2020-09-14	19,642	$0.00	980,030	No	5	G	Indirect	By self due to Control over the Entity that holds Shares

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Direct
No	4	A	Direct
No	4	P	Direct
No	4	P	Direct
No	5	G	Indirect	By self due to Control over the Entity that holds Shares

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2020-09-15	60,000	$0.00	60,000	$0.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
60,000		2030-09-15	No	4	A	Direct

Footnotes

On September 15, 2020, the reporting person was granted 13,580 restricted stock units ("RSUs") in lieu of a portion of cash compensation as a director of Brickell Biotech, Inc. The RSUs are scheduled to vest on December 31, 2020 and will be settled in the form of one share of common stock for each RSU.
Represents the purchase of 15,355 shares in multiple transactions, ranging in price from $0.80 to $0.8153 per share, resulting in a weighted average purchase price of $0.8086. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.
Represents the purchase of 14,645 shares in multiple transactions, ranging in price from $0.80 to $0.81 per share, resulting in a weighted average purchase price of $0.8029. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.
The stock options will vest 25% on September 15, 2021, and the remainder will vest in equal monthly installments over the following three years.